Pfizer Inc
Close on Oct 30, 2026Market cap $173.95BP/E 40.2Yield 5.64%
Pfizer Primary Care Portfolio Total [legacy pre-Q1 2026 by Quarter
Primary Care Portfolio Total [legacy pre-Q1 2026 realignment, through Q4 2025] ($M) ($M)
Pfizer Primary Care Portfolio Total [legacy pre-Q1 2026: $7,938M in Q4 2025, down 10.9% from a year earlier.
Where the Q4 2025 figure comes from
“|| Primary Care | $ | 7,938 | $ | 8,911 | (11%) | (13%) | $ | 3,547 | $ | 3,983 | (11%) | $ | 4,391 | $ | 4,928 | (11%) | (14%)”
Source: Form 8-K (Earnings / Guidance Release) (pfe-12312025xex99.htm, filed 2026-02-03) ↗
In Q1 2026, Pfizer carved Global Hospital & Biosimilars out of Primary Care & Specialty Care into a 4th category without restating Q4 2025.
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Breakdown
What makes up primary Care Portfolio Total [legacy pre-Q1 2026
- Primary Care Portfolio Total [legacy] — U.S. ($M)3,547 · Q4 2025
- Primary Care Portfolio Total [legacy] — International ($M)4,391 · Q4 2025
- Primary Care Portfolio Total [legacy] — Worldwide reported YoY (%)-11.0% · Q4 2025
- Primary Care Portfolio Total [legacy] — Worldwide operational YoY (%)-13.0% · Q4 2025
Cite this data
StockData. (2026). Pfizer Primary Care Portfolio Total [legacy pre-Q1 2026 ($M), quarterly Q3 2021–Q4 2025 [Data set]. Compiled from Pfizer SEC filings and investor materials. https://stockdatahq.com/stocks/pfe/kpis/port-leg-pc-ww
See every metric in the Pfizer KPI table. Data updated Nov 2, 2026.